← Eichor
Condition: Low Risk Prostate Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Low Risk Prostate Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.
NA · 1 location(s) · CHU de Quebec-Universite Laval · NCT06052683
The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance
NA · 1 location(s) · NHS Lothian · NCT06117059
Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
Phase N/A · 2 location(s) · Massachusetts General Hospital · NCT06862856
Spanish Urological Association Registry of Patients on Active Surveillance
Phase N/A · 1 location(s) · Fundación Instituto Valenciano de Oncología · NCT02865330
Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body Radiothe
NA · 20 location(s) · Center Eugene Marquis · NCT03830788
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
NA · 2 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT06138067
Safety and Efficacy of Two-step Radical Prostatectomy
Phase N/A · 1 location(s) · Sun Yat-sen University · NCT05722392
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
Phase 1 · 2 location(s) · Brigham and Women's Hospital · NCT06062745
Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genit
Phase 3 · 2 location(s) · Regina Elena Cancer Institute · NCT06717711
Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer
Phase N/A · 1 location(s) · British Columbia Cancer Agency · NCT06200974
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
NA · 1 location(s) · The Cleveland Clinic · NCT05868668
Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic
Phase 3 · 26 location(s) · Nick Beije · NCT07260435
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer
Phase 4 · 1 location(s) · Roswell Park Cancer Institute · NCT06733350
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
NA · 1 location(s) · Mayo Clinic · NCT05438563
Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial
NA · 1 location(s) · East and North Hertfordshire NHS Trust · NCT06915909
Biological Markers and Advanced Imaging for Prostate Cancer Progression in Active Surveillance
NA · 1 location(s) · Università Vita-Salute San Raffaele · NCT06866041
Feasibility Trial of Single-Dose Radiotherapy for Localized Low and Intermediate Risk Prostate Cancer
NA · 1 location(s) · Branch Office of "Hadassah Medical Ltd" · NCT07112781
Active Surveillance for Low Risk Prostate Cancer
Phase N/A · 1 location(s) · I.M. Sechenov First Moscow State Medical University · NCT04146077
Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)
Phase N/A · 1 location(s) · University of Lausanne Hospitals · NCT06482489
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Pro
Phase 2 · 3 location(s) · University of Washington · NCT06526299
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
Phase 3 · 1 location(s) · University of Texas Southwestern Medical Center · NCT03769766
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT06145633
Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer
NA · 1 location(s) · Rabin Medical Center · NCT06027892
First-in-human Diagnostic Imaging Profile of the Theranostic Pair [68Ga]Ga-DOTA-STR-17126 and Low Dose [177Lu] Lu-DOTA-S
EARLY_Phase 1 · 1 location(s) · Integrated Haematology and Oncology Network · NCT07608848
Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial
Phase 2 · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT02391051
Artificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate
Phase 2 · 1 location(s) · German Oncology Center, Cyprus · NCT06772441
Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial
NA · 1 location(s) · Hong Kong Sanatorium & Hospital · NCT07130682
Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate Cancer
NA · 1 location(s) · Fondazione del Piemonte per l'Oncologia · NCT05832736
Low to Moderate Load Power Training for Men With Metastatic Prostate Cancer.
NA · 1 location(s) · University of Alicante · NCT07572760
Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT03789253
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.